EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 19-Jun-2026 19:15 ET (19-Jun-2026 23:15 GMT/UTC)

AI-guided biochar design offers new pathway to tackle emerging water pollutants

Biochar Editorial Office, Shenyang Agricultural University
Peer-Reviewed Publication

Emerging pollutants such as pharmaceuticals, microplastics, and industrial chemicals are increasingly detected in water systems worldwide, raising concerns about long-term risks to ecosystems and human health. A new study highlights how artificial intelligence can transform biochar into a powerful, cost-effective solution for removing these persistent contaminants from water.

Journal: Biochar

Dr. Roxana Mehran is new American College of Cardiology president

American College of Cardiology
Business Announcement

Roxana Mehran, MD, FACC, today assumed the role of president of the American College of Cardiology. Mehran will serve a one-year term at the helm of the almost 60,000-member global cardiovascular organization as it works toward its mission to transform cardiovascular care and improve heart health for all.

Switching from dulaglutide to tirzepatide boosts patient-reported well-being for people with type 2 diabetes

American College of Physicians
Peer-Reviewed Publication

An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in blood sugar and weight but also reported feeling emotionally better.

Journal: Annals of Internal Medicine

New study identifies promising pathway to reverse pulmonary fibrosis

National Jewish Health
Peer-Reviewed Publication

Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The recent study published in Nature Communications(Opens in a new window) reveals that the protein BCL-2 impedes normal lung repair and that targeting it may restore lung health.

Journal: Nature Communications

A natural molecule present in the human body protects against the flu, Fisabio study reveals

Universidad Miguel Hernandez de Elche
Peer-Reviewed Publication

A study led by Fisabio (Spain) has characterized a previously undescribed mechanism of action that could be relevant for the development of new antiviral strategies for influenza and further respiratory viruses.

Journal: Proceedings of the National Academy of Sciences
Funder: Agència Valenciana de la Innovació, European Regional Development Fund, Ministerio de Economía y Competitividad

Ochsner hosts no-cost Iberville Parish health fair to promote cancer awareness and prevention

Ochsner Health System
Business Announcement

The event connected community members with local providers for health screenings, education and prevention resources.

Long-term durability of acoramidis efficacy in transthyretin amyloid cardiomyopathy

JAMA Network
Peer-Reviewed Publication

About The Study: In this open-label extension of the ATTRibute-CM randomized clinical trial, early and continuous acoramidis treatment resulted in sustained incremental reductions in all-cause mortality, cardiovascular-related mortality, and first cardiovascular hospitalization through month 54. These findings support the importance of early and continuous long-term treatment with acoramidis in transthyretin amyloid cardiomyopathy (ATTR-CM).

Journal: JAMA Cardiology

Bullying and peer victimization can trigger trauma symptoms in children, study finds

University of Florida
Peer-Reviewed Publication

Researchers found more than 40% of elementary school children who experienced bullying showed trauma symptoms, highlighting a major child mental health concern.

Journal: Journal of Clinical Child & Adolescent Psychology

New $20M effort aims to address critical gaps in care for people with single ventricle heart disease

American Heart Association
Grant and Award Announcement

The American Heart Association and Additional Ventures, a research foundation working toward a cure for single ventricle heart disease, have committed a combined $20M to advance a coordinated, collaborative approach to improving the ability to predict, prevent and treat health complications in people living with Fontan circulation.